The Clinical Implications of Tumor Mutational Burden in Osteosarcoma

BACKGROUND: Osteosarcoma (OTS) is aggressive bone malignancy without well-recognized prognosis biomarker. Tumor mutational burden (TMB) has been proved as effective biomarker in predicting clinical outcomes in several cancer types. However, its prognostic value in OTS remains unknown. In this study,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Xie, Lu, Yang, Yufei, Guo, Wei, Che, Dongxue, Xu, Jie, Sun, Xin, Liu, Kuisheng, Ren, Tingting, Liu, Xingyu, Yang, Yi, Ji, Tao, Tang, Xiaodong
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059407/
https://ncbi.nlm.nih.gov/pubmed/33898301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.595527
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires